Last reviewed · How we verify

NCT06763419

Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement

Recruiting now NA Last updated 8 January 2025
What this trial tests

NA trial testing External low level laser therapy in Temporomandibular Joint Disorders in 50 participants. Currently enrolling.

Timeline
25 December 2024
Primary endpoint
28 February 2025
28 February 2025

Quick facts

Lead sponsorNourhan M.Aly
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment50
Start date25 December 2024
Primary completion28 February 2025
Estimated completion28 February 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Nourhan M.Aly — full company profile →

Who can join

Adults 20 to 40, any sex, with Temporomandibular Joint Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the study was to compare the efficacy of internal versus external photobiomodulation (PBM) in the management of patients with TMJ internal derangements (TMJ-ID).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Temporomandibular Joint Disorders

Currently open trials in the same condition.

Other Nourhan M.Aly trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06763419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing